Author: WTN News

Roche NimbleGen and the California-based BioDiscovery have formed a strategic alliance to help genomic researchers more quickly arrive at important biological insights. Under the partnership, they will combine their technologies to offer a more complete analytical solution to genomic and life-science customers. Roche NimbleGen was...

Mediocre therapeutic results against a cancer that no other therapy has shown much success against does not mean that RNase-based therapies, such as the one being developed by Madison's Quintessence Biosciences, will not be effective against other types of cancers. In this edition of Biotech...

The Madison-based biopharmaceutical firm Centrose continues to make progress toward developing therapies for cancer. The company has announced that two of its lead drug candidates have demonstrated, in animal models, the ability to kill cancer cells in colorectal and non-small lung cancers. Centrose, which will...

As your technology business heads toward an initial public offering or a merger, the task of financial planning with stock options starts with leveraging the value of those options to the highest level, according to columnist and attorney Sverre Roang. In this WTN Guest Column,...

Spurred on by the 2007 acquisition of Madison's NimbleGen by the pharma giant Roche, Wisconsin officials and biotech companies are on the hunt for additional collaborations with large pharmaceutical firms. The 2008 BIO Convention in San Diego this month will provide the perfect opportunity for...

In what is being described as a powerful technology combination, Madison's Gentel Biosciences will team with Germany's Eppendorf AG under a license-and-supply agreement designed to advance protein array applications. With the deal, Gentel adds to its intellectual property footprint and gains access to new markets...

Hard-to-search wave files make e-discovery compliance a challenging proposition for organizations that have made the switch from traditional voice service to a unified communications platform. Unfortunately, the potential solution - voice recognition technology - is improving but not completely ready for prime time, leaving the...

The global medical device industry is even more robust than big pharma but there is a real synergy developing between the two that is important to the Midwestern states that boast of a strong medical device industry, notes columnist Michael Rosen. In this edition of...

Wisconsin's entrepreneurial climate is strengthened by individual quality and by an increasing number of new start-ups, according to columnist Tom Still. In this edition of Inside Wisconsin, Still touts encouraging entrepreneurial news from the likes of the Ewing Marion Kauffman Foundation, but he writes that...